282 related articles for article (PubMed ID: 21822604)
1. Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially.
Palazzuoli A; Ronco C
Heart Fail Rev; 2011 Nov; 16(6):503-8. PubMed ID: 21822604
[TBL] [Abstract][Full Text] [Related]
2. Cardio-renal syndromes: from foggy bottoms to sunny hills.
Ronco C
Heart Fail Rev; 2011 Nov; 16(6):509-17. PubMed ID: 21259069
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of renal dysfunction in heart failure.
Palazzuoli A; Beltrami M; Nodari S; McCullough PA; Ronco C
Rev Cardiovasc Med; 2011; 12(4):186-99. PubMed ID: 22249509
[TBL] [Abstract][Full Text] [Related]
4. Cardio-renal syndrome type 1: epidemiology, pathophysiology, and treatment.
Ismail Y; Kasmikha Z; Green HL; McCullough PA
Semin Nephrol; 2012 Jan; 32(1):18-25. PubMed ID: 22365158
[TBL] [Abstract][Full Text] [Related]
5. Cardiorenal Syndromes and Their Role in Water and Sodium Homeostasis.
Buryskova Salajova K; Malik J; Valerianova A
Physiol Res; 2024 Apr; 73(2):173-187. PubMed ID: 38710052
[TBL] [Abstract][Full Text] [Related]
6. RAAS inhibition and cardiorenal syndrome.
Onuigbo MA
Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic management of chronic reno-cardiac syndrome.
Hawwa N; Schreiber MJ; Tang WH
Curr Heart Fail Rep; 2013 Mar; 10(1):54-62. PubMed ID: 23143732
[TBL] [Abstract][Full Text] [Related]
8. Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review.
Singhania G; Ejaz AA; McCullough PA; Kluger AY; Balamuthusamy S; Dass B; Singhania N; Agarwal A
Rev Cardiovasc Med; 2019 Sep; 20(3):111-120. PubMed ID: 31601085
[TBL] [Abstract][Full Text] [Related]
9. Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology.
Mewton N; Girerd N; Boffa JJ; Courivaud C; Isnard R; Juillard L; Lamblin N; Legrand M; Logeart D; Mariat C; Meune E; Sabouret P; Sebbag L; Rossignol P
Arch Cardiovasc Dis; 2020 Oct; 113(10):660-670. PubMed ID: 32660835
[TBL] [Abstract][Full Text] [Related]
10. The role of early and sufficient isolated venovenous ultrafiltration in heart failure patients with pulmonary and systemic congestion.
Costanzo MR; Chawla LS; Tumlin JA; Herzog CA; McCullough PA; Kellum JA; Ronco C
Rev Cardiovasc Med; 2013; 14(2-4):e123-33. PubMed ID: 24448253
[TBL] [Abstract][Full Text] [Related]
11. Benefits and Risks of Continuing Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, and Mineralocorticoid Receptor Antagonists during Hospitalizations for Acute Heart Failure.
Oliveros E; Oni ET; Shahzad A; Kluger AY; Lo KB; Rangaswami J; McCullough PA
Cardiorenal Med; 2020; 10(2):69-84. PubMed ID: 32062648
[TBL] [Abstract][Full Text] [Related]
12. Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.
Carubelli V; Metra M; Lombardi C; Bettari L; Bugatti S; Lazzarini V; Dei Cas L
Heart Fail Rev; 2012 Mar; 17(2):271-82. PubMed ID: 21748453
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment.
Rajapakse NW; Nanayakkara S; Kaye DM
Pharmacol Ther; 2015 Oct; 154():1-12. PubMed ID: 25989232
[TBL] [Abstract][Full Text] [Related]
14. Global cardiovascular protection in chronic kidney disease.
Ruiz-Hurtado G; Sarafidis P; Fernández-Alfonso MS; Waeber B; Ruilope LM
Nat Rev Cardiol; 2016 Oct; 13(10):603-8. PubMed ID: 27053454
[TBL] [Abstract][Full Text] [Related]
15. Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.
Schmieder RE; Mitrovic V; Hengstenberg C
Clin Res Cardiol; 2015 Aug; 104(8):621-31. PubMed ID: 25787721
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
[TBL] [Abstract][Full Text] [Related]
17. Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection.
Palazzuoli A; McCullough PA; Ronco C; Nuti R
Intern Emerg Med; 2015 Aug; 10(5):543-54. PubMed ID: 25972236
[TBL] [Abstract][Full Text] [Related]
18. Heart failure in patients with kidney disease.
Tuegel C; Bansal N
Heart; 2017 Dec; 103(23):1848-1853. PubMed ID: 28716974
[TBL] [Abstract][Full Text] [Related]
19. Management and monitoring of haemodynamic complications in acute heart failure.
Aspromonte N; Cruz DN; Valle R; Ronco C
Heart Fail Rev; 2011 Nov; 16(6):575-81. PubMed ID: 21301959
[TBL] [Abstract][Full Text] [Related]
20. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.
Giam B; Kaye DM; Rajapakse NW
Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
